Evidence map›Paper›PMID 1318394›Full record

ArticleJournal of virology1992

Binding of the coronavirus mouse hepatitis virus A59 to its receptor expressed from a recombinant vaccinia virus depends on posttranslational processing of the receptor glycoprotein.

M N Pensiero, G S Dveksler, C B Cardellichio, G S Jiang, P E Elia, C W Dieffenbach, K V Holmes

Abstract read
In one paragraph

Article in Journal of virology, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. The molecular biology of coronaviruses.Advances in virus research · 2006
    Review
  6. Synthetic peptides from the N-domains of CEACAMs activate neutrophils.The journal of peptide research : official journal of the American Peptide Society · 2001
    Article
  7. Article
  8. Article
  9. Article
  10. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor.Proceedings of the National Academy of Sciences of the United States of America · 1993
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M N PensieroDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.
G S Dveksler
C B Cardellichio
G S Jiang
P E Elia
C W Dieffenbach
K V Holmes
Uniformed Services University of the Health Sciences · US

Funding

MOLECULAR GENETICS OF THE RECEPTOR FOR MVHR01AI025231 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, KATHRYN V · 1988 to 2007
$3.5M
FUNCTIONAL ANALYSIS OF HANTAAN VIRUS PROTEINSR01AI025376 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI HAY, JOHN I. · 1989 to 1993
–
NIAID NIH HHS AI25231NIAID NIH HHS AI25376
6 · The paper itself

Abstract

Recently, we showed that a murine member of the carcinoembryonic antigen family of glycoproteins serves as a cellular receptor (MHVR) for the coronavirus mouse hepatitis virus A59 (MHV-A59) (G. S. Dveksler, M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G.-S. Jiang, K. V. Holmes, and C. W. Dieffenbach, J. Virol. 65:6881-6891, 1991; R. K. Williams, G.-S. Jiang, and K. V. Holmes, Proc. Natl. Acad. Sci. USA 88:5533-5536, 1991). To examine the role of posttranscriptional modification of MHVR on virus-receptor interactions, a vaccinia virus-based expression system was employed. Expression from the vaccinia virus recombinant (Vac-MHVR) in BHK-21 cells resulted in high levels of MHVR glycoprotein on the cell surface and made these cells susceptible to MHV-A59 infection. Nonglycosylated core MHVR proteins were made in Vac-MHVR-infected BHK-21 cells in the presence of tunicamycin by in vitro translation of MHVR mRNA in a rabbit reticulocyte cell-free system in the absence of microsomal membranes and by expression of an N-terminal deletion clone of MHVR lacking its signal peptide. These three nonglycosylated MHVR proteins were recognized by polyclonal antibody against affinity-purified receptor but did not bind antireceptor monoclonal antibody (MAb) CC1 or MHV-A59 virions. Partial glycosylation of MHVR, either expressed in Vac-MHVR-infected cells treated with monensin or synthesized by in vitro translation with microsomal membranes, restored both the MAb CC1- and the virus-binding activities of the MHVR glycoprotein. Deletion of 26 amino acids at the carboxyl terminus of MHVR resulted in a secreted protein which was able to bind MAb CC1 and MHV-A59. These results suggest that either a carbohydrate moiety is an element of the MHVR-binding site(s) for virus and MAb CC1 or a posttranslational membrane-associated process is required for functional conformation of the receptor glycoprotein.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SequenceAnimalsBase SequenceCell LineDNA, ViralGene ExpressionGlycoproteinsImmunohistochemistryKineticsMolecular Sequence DataMurine hepatitis virusReceptors, VirusRecombinant ProteinsVaccinia virusDNA, ViralGlycoproteinsReceptors, VirusRecombinant Proteins

Identifiers

PMID1318394
PMCPMC241205
OpenAlexW1632906710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.